China Biopharma, Inc. (stock symbol changed from CBPC.OB to CHBO.OB), is a fast growing provider of human vaccine and other pharmaceutical products in China. Through its wholly owned subsidiary, China Biopharma Limited, the Company owns the majority interest of Zhejiang Tianyuan Biotech Co., Ltd. The Company's current products consist of human vaccines and other pharmaceutical products used by general hospital and clinic in China. With its investment and ownership of local Chinese biopharmaceutical companies, the Company plans to build a leading biopharmaceutical product provider in China by leveraging its manufacturing and marketing capabilities and introducing advanced technologies, best products, and experienced management teams. 

Press Release

China Biopharma, Inc. Issues Corporate Information Update	2008-12-26
China Biopharma Effects 1 for 100 Reverse Stock Split	2008-09-15
China Biopharma Inc Held Its 2008 Annual Meeting in Princeton, NJ	2008-08-15
China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products	2008-03-26
China Biopharma Inc Files SEC Form 10KSB - Annual Report	2008-03-25
China Biopharma, Inc. Announces New Plan of Operation	2007-11-20
Company's Partner Completes Trial Production of A New Antiviral Medicine	2007-10-15
China Biopharma to Introduce an Immunotherapeutic Vaccine into China	2007-06-26
>> More News and Events...